Phytotherapy Research · 11 Nov 2026
Artificial Intelligence for Precision Phytomedicine: A Critical Review and the Patient–Product–Mechanism–Response ( PPMR ) Framework
Mohamed Fared Shawky Mohamedh-index 0, Ahmed Mohsen Kamal El‐sagheir, Jen Chin Lin, Ming‐Kuem Lin, Yung‐Luen Yu, Jung Chaoh-index 0
Citations by database
Each database indexes a different set of journals, preprints and books, so they are shown side by side rather than blended.
- OpenCitations0
- Crossref0
- Europe PMC0
Citations per year
The current year is still counting.
- 2026 so far0
Abstract
ABSTRACT Plant‐derived preparations remain widely used, yet their clinical application is constrained by multicomponent composition, batch‐to‐batch chemical variability, and complex pharmacokinetics, poorly characterized interactions, and marked interindividual variability in response. Artificial intelligence (AI) and computational pharmacology offer analytical tools suited to the high‐dimensional data generated by phytomedicine, but enthusiasm has outpaced the supporting evidence. This critical narrative review evaluates AI applications across the phytomedicine pipeline, grading them by the strength and directness of evidence from computational prediction through in vitro, animal, observational, and randomized clinical studies. We organize the field around a Patient–Product–Mechanism–Response (PPMR) framework, arguing that meaningful personalization requires joint characterization of both the patient and the chemically variable botanical product. Current applications are most mature for botanical authentication, spectral annotation, quality assurance, and mechanism‐informed hypothesis generation, whereas validated tools for patient stratification, individualized product and dose selection, and improved clinical outcomes remain limited. Rather than claiming efficacy gains, we present AI as a means to advance standardized, mechanism‐informed, and testable phytomedicine, contingent on higher‐quality data, prospective external validation, and regulatory alignment. The central finding is that none of the studies examined demonstrated a complete AI‐guided personalized‐phytomedicine pathway from joint patient‐and‐product characterization through a prospectively validated individualized response; precision phytomedicine should therefore be described as an emerging and hypothesis‐generating research programme rather than an established clinical capability.
What the data shows
- No database records a citation yet, as is usual for a paper this new.
- Mohamed Fared Shawky Mohamed has the highest h-index among the authors (0).
Graph
This paper in the middle, its authors and their most-cited papers below, the papers it cites to the left and the papers citing it to the right. The timeline lays every paper out by year.
Select a node for its details. Drag to pan, scroll to zoom, drag a node to move it.
Start with
Cited by 0 papers
Who cites this paper, from open citation data, with Crossref's record of each; the 100 newest when there are more.
References (71)
What it cites, from open citation data, with Crossref's record of each.
Sign in to see 51 more references
A free account opens the rest of the citing papers and references on every paper’s page.